JFG
TWST icon

Jefferies Financial Group’s Twist Bioscience TWST Stock Holding History

Jefferies Financial Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-31,600
Closed -$647K – 2005
2023
Q2 		$647K Buy
+31,600
New +$473K 0.01% 1087
2023
Q1 		– Sell
-88,000
Closed -$2.1M – 2005
2022
Q4 		$2.1M Buy
+88,000
New +$2.55M 0.01% 640

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Jefferies Financial Group's TWST Position: Q3 2023 in Review

Jefferies Financial Group sold out of Twist Bioscience (TWST) in Q3 2023, closing a stake of 31,600 shares — an estimated $647K sold.

Jefferies Financial Group first reported a position in TWST in Q4 2022 and held it in 2 quarters. The position peaked at $2.1M in Q4 2022. 194 funds tracked by Wall St. Rank hold TWST as of Q3 2023.

  • Jefferies Financial Group reported no remaining Twist Bioscience position as of Q3 2023 after selling out during the quarter.
  • Jefferies Financial Group sold 31,600 Twist Bioscience shares in Q3 2023, an estimated $647K.
  • Jefferies Financial Group first reported a position in Twist Bioscience in Q4 2022 and held it in 2 quarters.
  • Jefferies Financial Group's Twist Bioscience position peaked at $2.1M in Q4 2022.
  • 194 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2023.

Based on Jefferies Financial Group's 13F filing for Q3 2023, filed 14 Nov 2023.